BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Dec. 22, 2010
View Archived Issues
EpiTherapeutics, Abbott in Epigenetics Oncology Deal
EpiTherapeutics ApS, which is developing cancer drugs based on epigenetics targets, entered its first drug discovery pact, with Abbott, of Abbott Park, Ill. (BioWorld International)
Read More
Xention Spins Out Provesica to Advance Bladder Drug
Read More
Genomics of Lung Cancer Yields a New Drug Target
Read More
NovImmune Tops Off Cash with $20M for Antibody Trials
Read More
Two Biotechs Merge to Form PsiOxus Therapeutics
Read More
Proximagen Picks up GSK's Discarded CNS Programs
Read More
Other News To Note
Read More